Outlook Therapeutics, Inc. (OTLK) › Net IncomeOutlook Therapeutics, Inc. (OTLK) — Net IncomeAnnual figures by period end, from SEC filings.2015-09-30: -$47.39M2016-09-30: -$53.30M2017-09-30: -$38.85M2018-09-30: -$30.09M2019-09-30: -$34.52M2020-09-30: -$35.24M2021-09-30: -$53.16M2022-09-30: -$66.05M2023-09-30: -$58.98M2024-09-30: -$75.37M2025-09-30: -$62.42M-$62.42M2015-09-30Net Income (USD)2025-09-30Period endedNet IncomeChange YoYSource filing2025-09-30-$62.42M—2025-12-19From 2024-10-012024-09-30-$75.37M—2025-12-19From 2023-10-012023-09-30-$58.98M—2024-12-27From 2022-10-012022-09-30-$66.05M—2023-12-22From 2021-10-012021-09-30-$53.16M—2022-12-29From 2020-10-012020-09-30-$35.24M—2021-12-23From 2019-10-012019-09-30-$34.52M—2020-12-23From 2018-10-012018-09-30-$30.09M—2019-12-19From 2017-10-012017-09-30-$38.85M—2018-12-18From 2016-10-012016-09-30-$53.30M—2017-12-29From 2015-10-012015-09-30-$47.39M—2016-12-29From 2014-10-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)